Study of ISM3412 in Participants With Locally Advanced/Metastatic Solid Tumors
Clinical trial NCT06414460 · RECRUITING
Trial details
- NCT number
- NCT06414460
- Sponsor
- InSilico Medicine Hong Kong Limited
- Status
- RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-04-25
- Primary completion
- 2028-03-31
- Enrollment
- 114
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.